NETTER-3: [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, Grade 1/2 (Ki-67 <10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden

View at publisher
Authors: Pamela L Kunz, Jaume Capdevila, MD, Thorvardur Halfdanarson,, MD Daniel M Halperin, Ken Herrmann, Marianne Pavel, Jiapan Xu, Dhrubajyoti Pathak, Simron Singh
Cited by: 1

Fields of Study & Subjects

Neuroendocrine Tumor Research Advances Lung Cancer Research Studies Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
Endocrine Abstracts
Publisher
Bioscientifica
Publication date
4 March 2026